Research graph
References from A 25-year Patent Landscape of Anti-Biofilm Strategies for Respiratory Tract Infections: Trends, Innovations, and Emerging Clinical Opportunities. Local targets link to admitted publications; unresolved targets remain external evidence.
Targeting bacterial biofilm-related genes with nanoparticle-based strategies
10.3389/fmicb.2024.1387114 · 2024 · External reference
Adherent biofilms in adenotonsillar diseases in children
10.1001/archoto.2007.18 · 2008 · External reference
10.1017/s0022215107008870
10.1017/s0022215107008870 · 2007 · External reference
The battle of probiotics and their derivatives against biofilms
10.2147/idr.s232982 · 2020 · External reference
The role of bacterial biofilms in chronic infections
10.1111/apm.12099 · 2013 · External reference
Diffusion retardation by binding of tobramycin in an alginate biofilm model
2016 · External reference
The role of bacterial biofilm in persistent infections and control strategies
10.4248/ijos11022 · 2011 · External reference
Cationic antimicrobial peptides: issues for potential clinical use
10.2165/00063030-200317040-00002 · 2003 · External reference
Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria
10.1016/j.jmii.2016.12.005 · 2017 · External reference
Bacterial biofilms in nature and disease
10.1146/annurev.mi.41.100187.002251 · 1987 · External reference
Host metabolites stimulate the bacterial proton motive force to enhance the activity of aminoglycoside antibiotics
2019 · External reference
Understanding biofilm resistance to antibacterial agents
10.1038/nrd1008 · 2003 · External reference
Endotracheal tube biofilm and its impact on the pathogenesis of ventilator-associated pneumonia. J
10.2478/jccm-2018-0011 · 2018 · External reference
Engineered bacteria for disease diagnosis and treatment using synthetic biology
10.1111/1751-7915.70080 · 2025 · External reference
Comprehensive vaccine design for commensal disease progression
10.1126/sciadv.1701797 · 2017 · External reference
Recent developments in antimicrobial polymers for biofilm inhibition
10.1039/d5cc06617d · 2026 · External reference
Directed vaccination against pneumococcal disease
10.1073/pnas.1603007113 · 2016 · External reference
Biofilms and their role in otorhinolaryngological disease
10.1017/s0022215108002193 · 2008 · External reference
Nanotechnology in combating biofilm: A smart and promising therapeutic strategy
10.3389/fmicb.2022.1028086 · 2023 · External reference
Multiple strategies for the application of medicinal plant-derived bioactive compounds in controlling microbial biofilm and virulence properties
10.3390/antibiotics14060555 · 2025 · External reference
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
10.1016/s0140-6736(24)01867-1 · 2024 · External reference
Living Microbial Drugs
10.1002/chem.202503523 · 2026 · External reference
Biofilms and infections of the upper respiratory tract
2010 · External reference
Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating
10.1152/jappl.1992.72.6.2271 · 1992 · External reference
Crumbling the castle: targeting DNABII proteins for collapsing bacterial biofilms as a therapeutic approach to treat disease and combat antimicrobial resistance
10.3390/antibiotics11010104 · 2022 · External reference
A patent review of antibiofilm fungal drugs (2002-present)
10.1080/07388551.2021.1874283 · 2021 · External reference
The resistance of Vibrio cholerae O1 El Tor strains to the typing phage 919TP, a member of K139 phage family
10.3389/fmicb.2016.00726 · 2016 · External reference
Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact
10.1086/430352 · 2005 · External reference
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
10.1038/35037627 · 2000 · External reference
A review of phytochemicals targeting bacterial biofilm and quorum sensing pathways: molecular, microbiological, and mechanistic insights
10.1007/s00203-026-04871-0 · 2026 · External reference
Responsive nitric oxide‐releasing antibacterial materials for biofilm‐associated infections: Mechanisms, design strategies, and applications
10.1002/rpm2.70059 · 2026 · External reference
Biofilm formation on three different endotracheal tubes: a prospective clinical trial
10.1186/s13054-020-03092-1 · 2020 · External reference
The evolution of human probiotics: challenges and prospects
10.1007/s12602-019-09628-4 · 2020 · External reference
The extracellular matrix protects P seudomonas aeruginosa biofilms by limiting the penetration of tobramycin
10.1111/1462-2920.12155 · 2013 · External reference
Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin
10.1128/aac.39.2.329 · 1995 · External reference
Unresolved reference
External reference
Evidence of bacterial biofilms in nasal polyposis
2010 · External reference
